EUVIMEDEUVIMED entdecken
Open Access

Antitumor activity of tanshinone and its nanoparticles on U14 cervical carcinoma-bearing mice

Ya Di, Qingjie Meng, Hongwei Yang, Kun Li, Liyan Cao, Ming Shi, Zhanzhao Fu, Hao Di

Nanobiomedicine · 2016

DOI: 10.1177/1849543516673446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanobiomedicine, 2016. Verfasst von Ya Di und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncology department, The First Hospital of Qinhuangdao, Qinhuangdao, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, tanshinone was extracted from Salvia miltiorrhiza. To improve the utilization and the dissolution of the drug, the tanshinone extractions were prepared at a pharmaceutical nanoscale and in the nanometer range of 100–200 nm. Then, the rate of tumor inhibition and the activity of antioxidant system and the thymus/spleen indices were investigated to find the antitumor effect of nanoparticles of tanshinone in cervical carcinoma-bearing mice. Our data suggest that tanshinone inhibits cervical tumor growth and the rates of tumor inhibition of all drug groups were more than 45%. The highest rate was 70.88% in the high dose of nanoscale tanshinone group. The activities of superoxide dismutase were higher in drug groups than in the model control group, and the concentrations of malondialdehyde were significantly lower. These findings suggested that tanshinone enhance the superoxide dismutase activity of the mice and decrease the malondialdehyde content. It may be one of the mechanisms of antitumor effect of tanshinone. The thymus index and spleen index were higher than normal control or model control. These data suggested that tanshinone also enhanced the immune system of mice.

Schlagwörter

Stichwörter der Autor:innen

HPLCTEMTanshinoneU14 cervical carcinoma-bearing miceantitumor

Autor:innen und Institutionen

  • Oncology department, The First Hospital of Qinhuangdao, Qinhuangdao, People's Republic of China.
  • Oncology department, Fengrun Hospital of Tangshan, Tangshan, People's Republic of China.
  • Oncology department, Lulong County Hospital of Qinhuangdao, Qinhuangdao, People's Republic of China.
  • Department of Biological Engineering, College of Environment and Chemical Engineering, Yanshan University, Qinhuangdao, People's Republic of China.
  • School of economics, Nankai University, Weijin Road, Tianjin, People's Republic of China.
  • Research department, Zhongde Securities, Beijing, People's Republic of China.

Zitieren

APA

Di, Y., Meng, Q., Yang, H., Li, K., Cao, L., Shi, M., Fu, Z., & Di, H. (2016). Antitumor activity of tanshinone and its nanoparticles on U14 cervical carcinoma-bearing mice. Nanobiomedicine. https://doi.org/10.1177/1849543516673446

Vancouver

Di Y, Meng Q, Yang H, Li K, Cao L, Shi M, et al. Antitumor activity of tanshinone and its nanoparticles on U14 cervical carcinoma-bearing mice. Nanobiomedicine. 2016. doi:10.1177/1849543516673446

BibTeX
@article{Di2016,
  author = {Di, Ya and Meng, Qingjie and Yang, Hongwei and Li, Kun and Cao, Liyan and Shi, Ming and Fu, Zhanzhao and Di, Hao},
  title = {Antitumor activity of tanshinone and its nanoparticles on U14 cervical carcinoma-bearing mice},
  journal = {Nanobiomedicine},
  year = {2016},
  doi = {10.1177/1849543516673446}
}
Kostenlos starten →